Elizabeth Garrett-Mayer - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biostatistics Biology

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Burris JL, Wahlquist AE, Alberg AJ, Cummings KM, Gray KM, Garrett-Mayer E, Carpenter MJ. A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus. Addictive Behaviors. 63: 82-88. PMID 27450153 DOI: 10.1016/J.Addbeh.2016.07.008  0.52
2015 Ford ME, Wei W, Moore LA, Burshell DR, Cannady K, Mack F, Ezerioha N, Ercole K, Garrett-Mayer E. Evaluating the reliability of the Attitudes to Randomized Trial Questionnaire (ARTQ) in a predominantly African American sample. Springerplus. 4: 411. PMID 26266082 DOI: 10.1186/S40064-015-1208-Z  0.52
2015 Panneer Selvam S, De Palma RM, Oaks JJ, Oleinik N, Peterson YK, Stahelin RV, Skordalakes E, Ponnusamy S, Garrett-Mayer E, Smith CD, Ogretmen B. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. Science Signaling. 8: ra58. PMID 26082434 DOI: 10.1126/Scisignal.Aaa4998  0.52
2015 Harper JL, De Costa AM, Garrett-Mayer E, Sterba KR. Incorporating Patient Satisfaction Metrics in Assessing Multidisciplinary Breast Cancer Care Quality. Southern Medical Journal. 108: 372-6. PMID 26079465 DOI: 10.1200/Jco.2013.31.31_Suppl.151  0.52
2015 Logan SL, Carpenter L, Leslie RS, Garrett-Mayer E, Hunt KJ, Charles J, Nicholas JS. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders. Journal of Child and Adolescent Psychopharmacology. 25: 323-36. PMID 25919445 DOI: 10.1089/Cap.2013.0119  0.52
2015 Tirodkar TS, Lu P, Bai A, Scheffel MJ, Gencer S, Garrett-Mayer E, Bielawska A, Ogretmen B, Voelkel-Johnson C. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner. The Journal of Biological Chemistry. 290: 13157-67. PMID 25839235 DOI: 10.1074/Jbc.M114.631325  0.52
2015 Rubinstein MP, Su EW, Suriano S, Cloud CA, Andrijauskaite K, Kesarwani P, Schwartz KM, Williams KM, Johnson CB, Li M, Scurti GM, Salem ML, Paulos CM, Garrett-Mayer E, Mehrotra S, et al. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunology, Immunotherapy : Cii. 64: 539-49. PMID 25676709 DOI: 10.1007/S00262-015-1655-Y  0.52
2015 Kappler CS, Guest ST, Irish JC, Garrett-Mayer E, Kratche Z, Wilson RC, Ethier SP. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Molecular Oncology. 9: 527-43. PMID 25454348 DOI: 10.1016/J.Molonc.2014.10.006  0.52
2015 Chiuzan C, Garrett-Mayer E, Yeatts SD. A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designs. Clinical Trials (London, England). 12: 24-33. PMID 25349178 DOI: 10.1177/1740774514555585  0.52
2015 Andrijauskaite K, Suriano S, Cloud CA, Li M, Kesarwani P, Stefanik LS, Moxley KM, Salem ML, Garrett-Mayer E, Paulos CM, Mehrotra S, Kochenderfer JN, Cole DJ, Rubinstein MP. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells Cancer Gene Therapy. DOI: 10.1038/cgt.2015.28  0.52
2014 Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, Ethier SP. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia (New York, N.Y.). 16: 644-55. PMID 25220592 DOI: 10.1016/J.Neo.2014.07.007  0.52
2014 Kesarwani P, Al-Khami AA, Scurti G, Thyagarajan K, Kaur N, Husain S, Fang Q, Naga OS, Simms P, Beeson G, Voelkel-Johnson C, Garrett-Mayer E, Beeson CC, Nishimura MI, Mehrotra S. Promoting thiol expression increases the durability of antitumor T-cell functions. Cancer Research. 74: 6036-47. PMID 25164014 DOI: 10.1158/0008-5472.Can-14-1084  0.52
2014 Venkata JK, An N, Stuart R, Costa LJ, Cai H, Coker W, Song JH, Gibbs K, Matson T, Garrett-Mayer E, Wan Z, Ogretmen B, Smith C, Kang Y. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma. Blood. 124: 1915-25. PMID 25122609 DOI: 10.1182/Blood-2014-03-559385  0.52
2014 Eby JM, Kang HK, Klarquist J, Chatterjee S, Mosenson JA, Nishimura MI, Garrett-Mayer E, Longley BJ, Engelhard VH, Mehrotra S, Le Poole IC. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell & Melanoma Research. 27: 1075-85. PMID 24935676 DOI: 10.1111/Pcmr.12284  0.52
2014 Logan SL, Carpenter L, Leslie RS, Hunt KS, Garrett-Mayer E, Charles J, Nicholas JS. Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 44: 2931-48. PMID 24929833 DOI: 10.1007/S10803-014-2156-0  0.52
2014 Mathew AR, Wahlquist AE, Garrett-Mayer E, Gray KM, Saladin ME, Carpenter MJ. Affective motives for smoking among early stage smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 16: 1387-93. PMID 24924155 DOI: 10.1093/Ntr/Ntu093  0.52
2014 Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1277-80. PMID 24638016 DOI: 10.1200/Jco.2013.53.8009  0.52
2014 Esnaola NF, Chaudhary UB, O'Brien P, Garrett-Mayer E, Camp ER, Thomas MB, Cole DJ, Montero AJ, Hoffman BJ, Romagnuolo J, Orwat KP, Marshall DT. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 88: 837-44. PMID 24606850 DOI: 10.1016/J.Ijrobp.2013.12.030  0.52
2014 Gosnell H, Kasman LM, Potta T, Vu L, Garrett-Mayer E, Rege K, Voelkel-Johnson C. Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 176: 35-43. PMID 24370892 DOI: 10.1016/J.Jconrel.2013.12.012  0.52
2014 Rossmann C, Garrett-Mayer E, Rattay F, Haemmerich D. Dynamics of tissue shrinkage during ablative temperature exposures. Physiological Measurement. 35: 55-67. PMID 24345880 DOI: 10.1088/0967-3334/35/1/55  0.52
2014 Opfermann KJ, Wahlquist AE, Garrett-Mayer E, Shridhar R, Cannick L, Marshall DT. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. American Journal of Clinical Oncology. 37: 112-6. PMID 23211221 DOI: 10.1097/Coc.0B013E31826E0570  0.52
2013 Rudek MA, Connolly RM, Hoskins JM, Garrett-Mayer E, Jeter SC, Armstrong DK, Fetting JH, Stearns V, Wright LA, Zhao M, Watkins SP, McLeod HL, Davidson NE, Wolff AC. Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer. Breast Cancer Research and Treatment. 139: 135-43. PMID 23588952 DOI: 10.1007/S10549-013-2516-Z  0.52
2013 Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, Kumar P, Denman CJ, Lacek AT, Kohlhapp FJ, Alamiri A, Hughes T, Bines SD, Kaufman HL, Overbeck A, et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Science Translational Medicine. 5: 174ra28. PMID 23447019 DOI: 10.1126/Scitranslmed.3005127  0.52
2013 Hollis BW, Marshall DT, Savage SJ, Garrett-Mayer E, Kindy MS, Gattoni-Celli S. Vitamin D3 supplementation, low-risk prostate cancer, and health disparities. The Journal of Steroid Biochemistry and Molecular Biology. 136: 233-7. PMID 23220550 DOI: 10.1016/J.Jsbmb.2012.11.012  0.52
2013 Saddoughi SA, Gencer S, Peterson YK, Ward KE, Mukhopadhyay A, Oaks J, Bielawski J, Szulc ZM, Thomas RJ, Selvam SP, Senkal CE, Garrett-Mayer E, De Palma RM, Fedarovich D, Liu A, et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. Embo Molecular Medicine. 5: 105-21. PMID 23180565 DOI: 10.1002/Emmm.201201283  0.52
2013 Hudspeth MP, Heath TS, Chiuzan C, Garrett-Mayer E, Nista E, Burton L, Ragucci D. Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT. Bone Marrow Transplantation. 48: 46-9. PMID 22609886 DOI: 10.1038/Bmt.2012.82  0.52
2012 Ford M, Wahlquist A, Blake R, Green C, Streets J, Fuller E, Johnson E, Jefferson M, Etheredge J, Varner H, Johnson S, Glover S, Turner D, Garrett-Mayer E. Assessing an intervention to improve clinical trial perceptions among predominately African-American communities in South Carolina. Progress in Community Health Partnerships : Research, Education, and Action. 6: 249-63. PMID 22982839 DOI: 10.1353/Cpr.2012.0038  0.52
2012 Weekes CD, Song D, Arcaroli J, Wilson LA, Rubio-Viqueira B, Cusatis G, Garrett-Mayer E, Messersmith WA, Winn RA, Hidalgo M. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia (New York, N.Y.). 14: 690-701. PMID 22952422 DOI: 10.1593/Neo.111810  0.52
2012 Mehrotra S, Al-Khami AA, Klarquist J, Husain S, Naga O, Eby JM, Murali AK, Lyons GE, Li M, Spivey ND, Norell H, Martins da Palma T, Onicescu G, Diaz-Montero CM, Garrett-Mayer E, et al. A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. Journal of Immunology (Baltimore, Md. : 1950). 189: 1627-38. PMID 22798675 DOI: 10.4049/Jimmunol.1103271  0.52
2012 Garrett-Mayer E, Wagner CL, Hollis BW, Kindy MS, Gattoni-Celli S. Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white men. The American Journal of Clinical Nutrition. 96: 332-6. PMID 22760568 DOI: 10.3945/Ajcn.112.034256  0.52
2012 Karp JE, Garrett-Mayer E, Estey EH, Rudek MA, Douglas Smith B, Greer JM, Michelle Drye D, Mackey K, Dorcy KS, Gore SD, Levis MJ, McDevitt MA, Carraway HE, Pratz KW, Gladstone DE, et al. Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia Haematologica. 97: 1736-1742. PMID 22733022 DOI: 10.3324/Haematol.2012.062539  0.52
2012 Van Meter EM, Garrett-Mayer E, Bandyopadhyay D. Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method. Clinical Trials (London, England). 9: 303-13. PMID 22547420 DOI: 10.1177/1740774512443593  0.52
2012 Marshall DT, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Horst RL, Ambrose LH, Kindy MS, Gattoni-Celli S. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. The Journal of Clinical Endocrinology and Metabolism. 97: 2315-24. PMID 22508710 DOI: 10.1210/Jc.2012-1451  0.52
2012 Kaseb AO, Garrett-Mayer E, Morris JS, Xiao L, Lin E, Onicescu G, Hassan MM, Hassabo HM, Iwasaki M, Deaton FL, Abbruzzese JL, Thomas MB. Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. Oncology. 82: 67-74. PMID 22327795 DOI: 10.1159/000335963  0.52
2012 Logan SL, Nicholas JS, Carpenter LA, King LB, Garrett-Mayer E, Charles JM. High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Annals of Epidemiology. 22: 1-8. PMID 22153288 DOI: 10.1016/J.Annepidem.2011.10.007  0.52
2012 Zauls AJ, Watkins JM, Wahlquist AE, Brackett NC, Aguero EG, Baker MK, Jenrette JM, Garrett-Mayer E, Harper JL. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. International Journal of Radiation Oncology, Biology, Physics. 82: 21-9. PMID 20951508 DOI: 10.1016/J.Ijrobp.2010.08.034  0.52
2011 Curran JN, Garrett-Mayer E, Carpenter MJ, Ford ME, Silvestri GA, Lackland DT, Alberg AJ. Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Research. 31: 3891-5. PMID 22110215  0.52
2011 Prowell TM, Blackford AL, Byrne C, Khouri NF, Dowsett M, Folkerd E, Tarpinian KS, Powers PP, Wright LA, Donehower MG, Jeter SC, Armstrong DK, Emens LA, Fetting JH, Wolff AC, ... Garrett-Mayer E, et al. Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole. Cancer Prevention Research (Philadelphia, Pa.). 4: 1993-2001. PMID 21885816 DOI: 10.1158/1940-6207.Capr-11-0154  0.52
2011 Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA, Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, et al. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6097-105. PMID 21791630 DOI: 10.1158/1078-0432.Ccr-11-0930  0.52
2011 Kraft AS, Garrett-Mayer E, Wahlquist AE, Golshayan A, Chen CS, Butler W, Bearden J, Lilly M. Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biology & Therapy. 12: 119-24. PMID 21532336 DOI: 10.4161/Cbt.12.2.15723  0.52
2011 Ryan KK, Garrett-Mayer E, Alberg AJ, Cartmell KB, Carpenter MJ. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 646-52. PMID 21464200 DOI: 10.1093/Ntr/Ntr051  0.52
2011 Gopal U, Bohonowych JE, Lema-Tome C, Liu A, Garrett-Mayer E, Wang B, Isaacs JS. A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. Plos One. 6: e17649. PMID 21408136 DOI: 10.1371/Journal.Pone.0017649  0.52
2011 Leoutsakos JM, Bandeen-Roche K, Garrett-Mayer E, Zandi PP. Incorporating scientific knowledge into phenotype development: penalized latent class regression. Statistics in Medicine. 30: 784-98. PMID 21394753 DOI: 10.1002/Sim.4137  0.52
2011 Connolly RM, Rudek MA, Garrett-Mayer E, Jeter SC, Donehower MG, Wright LA, Zhao M, Fetting JH, Emens LA, Stearns V, Davidson NE, Baker SD, Wolff AC. Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer. Breast Cancer Research and Treatment. 127: 153-62. PMID 21350820 DOI: 10.1007/S10549-011-1413-6  0.52
2011 Van Meter EM, Garrett-Mayer E, Bandyopadhyay D. Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading. Statistics in Medicine. 30: 2070-80. PMID 21344472 DOI: 10.1002/Sim.4069  0.52
2011 Ford ME, Wahlquist AE, Ridgeway C, Streets J, Mitchum KA, Harper RR, Hamilton I, Etheredge JJ, Jefferson MS, Varner H, Campbell K, Garrett-Mayer E. Evaluating an intervention to increase cancer knowledge in racially diverse communities in South Carolina. Patient Education and Counseling. 83: 256-60. PMID 20674239 DOI: 10.1016/J.Pec.2010.05.028  0.52
2010 Scharpf RB, Iacobuzio-Donahue CA, Cope L, Ruczinski I, Garrett-Mayer E, Lakkur S, Campagna D, Parmigiani G. Cross-platform Comparison of Two Pancreatic Cancer Phenotypes. Cancer Informatics. 9: 257-64. PMID 21082040 DOI: 10.4137/Cin.S5755  0.52
2010 Watkins JM, Wahlquist AE, Zauls AJ, Shirai K, Garrett-Mayer E, Aguero EG, Silvestri GA, Sherman CA, Sharma AK. Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival. Journal of Medical Imaging and Radiation Oncology. 54: 483-9. PMID 20958948 DOI: 10.1111/J.1754-9485.2010.02201.X  0.52
2010 Watkins JM, Fortney JA, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Sherman CA, Turrisi AT, Sharma AK. Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes. Japanese Journal of Radiology. 28: 340-8. PMID 20585921 DOI: 10.1007/S11604-010-0429-X  0.52
2010 Ivy SP, Siu LL, Garrett-Mayer E, Rubinstein L. Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1726-36. PMID 20215542 DOI: 10.1158/1078-0432.Ccr-09-1961  0.52
2010 Cunningham JE, Montero AJ, Garrett-Mayer E, Berkel HJ, Ely B. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes & Control : Ccc. 21: 399-409. PMID 20024610 DOI: 10.1007/S10552-009-9472-2  0.52
2010 Watkins JM, Zauls AJ, Wahlquist AH, Shirai K, Garrett-Mayer E, Gillespie MB, Day TA, Sharma AK. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. The Laryngoscope. 120: 236-42. PMID 19950378 DOI: 10.1002/lary.20536  0.52
2010 Ruppert BN, Watkins JM, Shirai K, Wahlquist AE, Garrett-Mayer E, Aguero EG, Sherman CA, Reed CE, Sharma AK. Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer. American Journal of Clinical Oncology. 33: 346-52. PMID 19841574 DOI: 10.1097/Coc.0B013E3181Aaca26  0.52
2010 Harper JL, Watkins JM, Zauls AJ, Wahlquist AE, Garrett-Mayer E, Baker MK, Cole DJ, Dragun AE, Jenrette JM. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. American Journal of Surgery. 199: 204-9. PMID 19837390 DOI: 10.1016/J.Amjsurg.2009.03.005  0.52
2009 Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM. Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. Spine. 34: 2096-103. PMID 19730217 DOI: 10.1097/Brs.0B013E3181B1Fab2  0.52
2009 Yang C, Garrett-Mayer E, Schneider JS, Gollomp SM, Tilley BC. Repeatable battery for assessment of neuropsychological status in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1453-60. PMID 19452561 DOI: 10.1002/Mds.22552  0.52
2009 Carpenter MJ, Garrett-Mayer E, Vitoc C, Cartmell K, Biggers S, Alberg AJ. Adolescent nondaily smokers: favorable views of tobacco yet receptive to cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 348-55. PMID 19366985 DOI: 10.1093/Ntr/Ntp023  0.52
2009 Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD, Scott T, Schwartz CL. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer. 115: 2514-22. PMID 19338063 DOI: 10.1002/Cncr.24286  0.52
2009 Nonemaker JM, Garrett-Mayer E, Carpenter MJ, Ford ME, Silvestri G, Lackland DT, Alberg AJ. The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Annals of Epidemiology. 19: 304-10. PMID 19269855 DOI: 10.1016/J.Annepidem.2008.12.017  0.52
2009 Watkins JM, Shirai KS, Wahlquist AE, Stuart RK, Chaudhary UB, Garrett-Mayer E, Day TA, Gillespie MB, Sharma AK. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head & Neck. 31: 493-502. PMID 19156831 DOI: 10.1002/Hed.20986  0.52
2009 Watkins JM, Marshall DT, Patel S, Giglio P, Herrin AE, Garrett-Mayer E, Jenrette JM. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. Journal of Neuro-Oncology. 93: 343-8. PMID 19142584 DOI: 10.1007/S11060-008-9779-Y  0.52
2009 Watkins JM, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Fortney JA, Sherman CA, Sharma AK. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 74: 1108-13. PMID 19084345 DOI: 10.1016/J.Ijrobp.2008.09.013  0.52
2009 Su SC, Caffo B, Garrett-Mayer E, Bassett SS. Modified test statistics by inter-voxel variance shrinkage with an application to f MRI. Biostatistics (Oxford, England). 10: 219-27. PMID 18723853 DOI: 10.1093/Biostatistics/Kxn028  0.52
2009 Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunology, Immunotherapy : Cii. 58: 49-59. PMID 18446337 DOI: 10.1007/S00262-008-0523-4  0.52
2008 Blum C, Graham A, Yousefzadeh M, Shrout J, Benjamin K, Krishna M, Hoda R, Hoda R, Cole DJ, Garrett-Mayer E, Reed C, Wallace M, Mitas M. The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. International Journal of Oncology. 33: 579-84. PMID 18695889 DOI: 10.3892/Ijo_00000043  0.52
2008 McRackan TR, Watkins JM, Herrin AE, Garrett-Mayer EM, Sharma AK, Day TA, Gillespie MB. Effect of body mass index on chemoradiation outcomes in head and neck cancer. The Laryngoscope. 118: 1180-5. PMID 18475213 DOI: 10.1097/MLG.0b013e31816fca5c  0.52
2008 Abukhdeir AM, Vitolo MI, Argani P, De Marzo AM, Karakas B, Konishi H, Gustin JP, Lauring J, Garay JP, Pendleton C, Konishi Y, Blair BG, Brenner K, Garrett-Mayer E, Carraway H, et al. Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proceedings of the National Academy of Sciences of the United States of America. 105: 288-93. PMID 18162533 DOI: 10.1073/Pnas.0710887105  0.52
2007 Beldner MA, Sherman CA, Green MR, Garrett-Mayer E, Chaudhary U, Meyer ML, Kraft AS, Montero AJ. Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer. Bmc Cancer. 7: 231. PMID 18096059 DOI: 10.1186/1471-2407-7-231  0.52
Show low-probability matches.